-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $10

Benzinga·03/16/2026 11:16:42
Listen to the news
HC Wainwright & Co. analyst Lander Egaña Gorroño initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $10.